The Centers for Disease Control and Prevention today issued updated recommendations for managing and reporting Shigella infections that were treated with ciprofloxacin or azithromycin and resulted in possible clinical treatment failure. “If treatment failure is suspected, clinicians should consider consulting an infectious disease specialist to identify best treatment options, and submit a stool specimen for antimicrobial susceptibility testing,” CDC said. “Clinicians should monitor patients carefully and report cases of possible clinical treatment failure to CDC.” Shigella bacteria can cause Shigellosis, a diarrheal disease that should be reported to local health departments. 

Related News Articles

Headline
The CDC has confirmed 90 cases of acute flaccid myelitis in 27 states so far this year, triple the number in 2017, according to a report the agency released…
Headline
Hospitals report improved preparedness for emerging infectious diseases since the Ebola outbreak in 2014.
Headline
The Centers for Disease Control and Prevention yesterday announced that it has confirmed 62 cases of acute flaccid myelitis – a polio-like illness that mostly…
Headline
Health care and public health leaders, clinicians and first responders can register to attend an Aug. 7-8 workshop in Atlanta on preparing for Ebola and other…